New Delhi, 29 August 2025: Samsung India, in collaboration with NeuroLogica, a subsidiary of Samsung Electronics Co., Ltd., has introduced its next-generation mobile CT product portfolio in India, aiming to make advanced diagnostic imaging more accessible and patient-focused.

The newly launched portfolio includes CereTom® Elite, OmniTom® Elite, OmniTom® Elite PCD, and BodyTom® 32/64, each designed to address diverse clinical needs across hospitals, specialty centres, and community health setups. With features such as AI-powered efficiency, enhanced mobility, and patient-first design, the systems are expected to significantly improve diagnostic and interventional radiology.

A key highlight of the launch is its focus on democratising healthcare access. By enabling adoption beyond metro cities and into tier-2 and tier-3 regions, Samsung aims to bridge the care gap and bring world-class imaging closer to patients.

“Samsung is taking a decisive step toward making advanced medical imaging more accessible, efficient, and patient-centric with the launch of the mobile CT solutions in India,” said Atantra Das Gupta, Head of HME Business, Samsung India.

These solutions are expected to play a crucial role in critical care areas such as stroke, trauma, and neurosurgery, empowering healthcare providers with real-time imaging and faster decision-making.

With this launch, Samsung strengthens its role in advancing India’s healthcare infrastructure and supporting improved patient outcomes across specialties.